New hope drug enters human testing for tough cancers
Disease control
Recruiting now
This is the first study in people testing a new drug called CTX-8371 for several advanced cancers that have stopped responding to standard treatments. Researchers will give increasing doses to a small group of patients to check if the drug is safe and what side effects it causes.…
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC